CoChat

Impact of Expert Pathologic Review of Lymphoma Diagnosis: Study of Patients From the French Lymphopath Network

Laurent, Camille, Baron, Marine, Amara, Nadia, Haioun, Corinne, Dandoit, Mylène, Maynadié, Marc, Parrens, Marie, Vergier, Beatrice, Copie-Bergman, Christiane, Fabiani, Bettina, Traverse-Glehen, Alexandra, Brousse, Nicole, Copin, Marie-Christine, Tas, Patrick, Petrella, Tony, Rousselet, Marie-Christine, Brière, Josette, Charlotte, Fréderic, Chassagne-Clement, Catherine, Rousset, Thérèse, Xerri, Luc, Moreau, Anne, Martin, Antoine, Damotte, Diane, Dartigues, Peggy, Soubeyran, Isabelle, Peoch, Michel, Dechelotte, Pierre, Michiels, Jean-François, de Mascarel, Antoine, Berger, Françoise, Bossard, Céline, Arbion, Flavie, Quintin-Roué, Isabelle, Picquenot, Jean-Michel, Patey, Martine, Fabre, Blandine, Sevestre, Henri, Le Naoures, Cécile, Chenard-Neu, Marie-Pierre, Bastien, Claire, Thiebault, Sylvie, Martin, Laurent, Delage, Manuela, Filleron, Thomas, Salles, Gilles, Molina, Thierry Jo, Delsol, Georges, Brousset, Pierre, Gaulard, Philippe · 2017 · Journal of Clinical Oncology
Cited by 230

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Purpose: To prospectively assess the clinical impact of expert review of lymphoma diagnosis in France. Materials and Methods: From January 2010 to December 2013, 42,145 samples from patients with newly diagnosed or suspected lymphomas were reviewed, according to the 2008 WHO classification, in real time by experts through the Lymphopath Network. Changes in diagnosis between referral and expert review were classified as major or minor according to their potential impact on patient care. Results: The 42,145 reviewed samples comprised 36,920 newly diagnosed mature lymphomas, 321 precursor lymphoid neoplasms, 314 myeloid disorders, and 200 nonhematopoietic neoplasms, with 4,390 benign lesions. There were 4,352 cutaneous and 32,568 noncutaneous lymphomas. The most common mature noncutaneous lymphomas were diffuse large B-cell lymphomas (32.4%), follicular lymphomas (15.3%), classic Hodgkin lymphomas (13%), peripheral T-cell lymphomas (6.3%) of which angioimmunoblastic T-cell lymphomas (2.3%) were the most frequent, and mucosa-associated lymphoid tissue lymphomas (5.8%). A diagnostic change between referral and expert review occurred in 19.7% of patients, with an estimated impact on patient care for 17.4% of patients. This rate was significantly higher for patients sent with a provisional diagnosis seeking expert second opinion (37.8%) than for patients sent with a formal diagnosis (3.7%). The most frequent discrepancies were misclassifications in lymphoma subtype (41.3%), with 12.3% being misclassifications among small B-cell lymphoma entities. Fewer than 2% of changes were between benign and malignant lymphoid conditions. Minor changes (2.3%) mostly consisted of follicular lymphoma misgrading and diffuse large B-cell lymphoma subtype misclassification. Conclusion: To our knowledge, this study provides the largest ever description of the distribution of lymphoma entities in a western country and highlights how expert review significantly contributes to a precise lymphoma diagnosis and optimal clinical management in a proportion of patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.2016.71.2083

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

Metadata

Authors
Laurent, C., Baron, M., Amara, N., Haioun, C., Dandoit, M., Maynadié, M., Parrens, M., Vergier, B., Copie-Bergman, C., Fabiani, B., Traverse-Glehen, A., Brousse, N., Copin, M.-C., Tas, P., Petrella, T., Rousselet, M.-C., Brière, J., Charlotte, F., Chassagne-Clement, C., Rousset, T., Xerri, L., Moreau, A., Martin, A., Damotte, D., Dartigues, P., Soubeyran, I., Peoch, M., Dechelotte, P., Michiels, J.-F., de Mascarel, A., Berger, F., Bossard, C., Arbion, F., Quintin-Roué, I., Picquenot, J.-M., Patey, M., Fabre, B., Sevestre, H., Le Naoures, C., Chenard-Neu, M.-P., Bastien, C., Thiebault, S., Martin, L., Delage, M., Filleron, T., Salles, G., Molina, T. J., Delsol, G., Brousset, P., & Gaulard, P.
Venue
Journal of Clinical Oncology
Published
2017-06-20
Volume
35
Issue
18
Pages
2008-2017
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W2610939428
Cited by
230
References
3
FWCI
14.46
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.